Nutra Pharma Corp. (NPHC)
Develops and sells pain relievers and drugs for neurological and autoimmune diseases.
$0.00-0.33%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+200.0%
The outlook
NPHC is trading near its 52-week lows at $0.0002, well below both its 50- and 200-day moving averages. The StockGlow score is bearish, and the stock sits just 2% up from its 52-week bottom, suggesting sustained downward pressure. Analyst coverage appears minimal for this micro-cap name.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$1.4M
52-wk high
$0.01
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—